Description

NSE announces listing of Anlon Healthcare Limited equity shares from IPO effective September 3, 2025 at issue price of Rs. 91 per share

Summary

The National Stock Exchange has announced the listing of 53,151,500 equity shares of Anlon Healthcare Limited following its Initial Public Offering (IPO). The shares will commence trading on September 3, 2025, under the symbol ‘AHCL’ in the BE series at an issue price of Rs. 91 per share with a face value of Rs. 10 each.

Key Points

  • Trading symbol: AHCL (BE series, later shifting to EQ series)
  • Total shares listed: 53,151,500 equity shares
  • Issue price: Rs. 91 per share
  • Face value: Rs. 10 per share fully paid up
  • ISIN: INE0Y8W01017
  • Market lot: 1 share
  • Pre-open session applicable for IPO category

Regulatory Changes

The securities will initially trade in Series ‘BE’ and subsequently shift to Series ‘EQ’ as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012. The shares will participate in pre-open sessions for IPO category scrips.

Compliance Requirements

  • Members must use the designated security code ‘AHCL’ for trading
  • Trading must comply with NSE Capital Market Trading Regulations Part A
  • Lock-in periods apply to various tranches of shares as specified
  • Company must maintain compliance officer and registrar services

Important Dates

  • Listing effective date: September 3, 2025
  • Lock-in expiry dates:
    • 10,630,300 shares: September 3, 2028
    • 17,369,700 shares: September 3, 2026
    • 11,851,500 shares: March 3, 2026
    • 13,300,000 shares: Free from lock-in

Impact Assessment

The listing adds a new healthcare sector company to NSE with approximately Rs. 484 crore market capitalization at issue price. With 25% shares free from lock-in and remaining 75% under various lock-in periods, initial liquidity may be constrained. The company operates in the healthcare sector from Rajkot, Gujarat, potentially offering investors exposure to the pharmaceutical/healthcare segment.

Impact Justification

New IPO listing with significant market capitalization and lock-in provisions affecting liquidity